Literature DB >> 22890458

Management of children with ambulatory cerebral palsy: an evidence-based review.

Unni G Narayanan1.   

Abstract

This article reviews the current best evidence for musculoskeletal interventions in children with ambulatory cerebral palsy (CP). The effectiveness of interventions in CP must first consider what CP and its associated pathophysiology are and take into account the heterogeneity and natural history of CP to put definitions of "effectiveness" into perspective. This article reviews the current standards of the definition and classification of CP, discusses the natural history and specific goals for the management of ambulatory CP, as well as the outcome measures available to measure these goals. The current best evidence of effectiveness is reviewed for specific interventions in children with ambulatory CP including spasticity management with botulinum toxin A injections and selective dorsal rhizotomy; multilevel orthopaedic surgery to address contractures and bony deformity; and the role of gait analysis for surgical decision-making before orthopaedic surgery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890458     DOI: 10.1097/BPO.0b013e31825eb2a6

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  18 in total

1.  Spastic Paralysis of the Elbow and Forearm.

Authors:  Idris Gharbaoui; Katarzyna Kania; Patrick Cole
Journal:  Semin Plast Surg       Date:  2016-02       Impact factor: 2.314

Review 2.  [Bilateral spastic cerebral palsy with ambulatory ability (diplegia): pathophysiology, state of the art of conservative and surgical treatment and rehabilitation].

Authors:  B Westhoff; D Bittersohl; R Krauspe
Journal:  Orthopade       Date:  2014-07       Impact factor: 1.087

3.  Stability of serial range-of-motion measurements of the lower extremities in children with cerebral palsy: can we do better?

Authors:  Johanna Darrah; Lesley Wiart; Jan Willem Gorter; Mary Law
Journal:  Phys Ther       Date:  2014-02-20

Review 4.  Lumbosacral Dorsal Rhizotomy for Spastic Cerebral Palsy: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-06

5.  Computerized Adaptive Tests Detect Change Following Orthopaedic Surgery in Youth with Cerebral Palsy.

Authors:  M J Mulcahey; Mary D Slavin; Pengsheng Ni; Lawrence C Vogel; Scott H Kozin; Stephen M Haley; Alan M Jette
Journal:  J Bone Joint Surg Am       Date:  2015-09-16       Impact factor: 5.284

Review 6.  Challenging neurological symptoms in paediatric palliative care: An approach to symptom evaluation and management in children with neurological impairment.

Authors:  Lisa Ann Rasmussen; Marie-Claude Grégoire
Journal:  Paediatr Child Health       Date:  2015-04       Impact factor: 2.253

Review 7.  A Systematic Review of the Effects of Single-Event Multilevel Surgery on Gait Parameters in Children with Spastic Cerebral Palsy.

Authors:  Robert P Lamberts; Marlette Burger; Jacques du Toit; Nelleke G Langerak
Journal:  PLoS One       Date:  2016-10-18       Impact factor: 3.240

8.  The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trial.

Authors:  Siri Merete Brændvik; Karin Roeleveld; Guro Lillemoen Andersen; Anne Elisabeth Ross Raftemo; Kjersti Ramstad; Jasmina Majkic-Tajsic; Torarin Lamvik; Bendik Lund; Turid Follestad; Torstein Vik
Journal:  Trials       Date:  2017-02-06       Impact factor: 2.279

9.  Impairments, activity limitations, and participation restrictions of the international classification of functioning, disability, and health model in children with ambulatory cerebral palsy.

Authors:  Akmer Mutlu; Sema Büğüşan; Özgün K Kara
Journal:  Saudi Med J       Date:  2017-02       Impact factor: 1.484

10.  Single-event multilevel surgery in cerebral palsy: Value added by a co-surgeon.

Authors:  Nickolas J Nahm; Meryl Ludwig; Rachel Thompson; Kenneth J Rogers; Ahmet Imerci; Kirk W Dabney; Freeman Miller; Julieanne P Sees
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.